- Home
- BOX vs VKTX Comparison
BOX vs VKTX Comparison
Compare BOX & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOX | VKTX |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BOX | VKTX |
|---|---|---|
| Price | $31.37 | $35.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $35.57 | ★ $95.86 |
| AVG Volume (30 Days) | 2.7M | ★ 5.3M |
| Earning Date | 05-26-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $506,142,000.00 | N/A |
| Revenue This Year | $9.41 | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $179.56 | ★ N/A |
| Revenue Growth | ★ 26.98 | N/A |
| 52 Week Low | $21.34 | $25.04 |
| 52 Week High | $36.34 | $43.15 |
Technical Indicators
Market Signals| Indicator | BOX | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.00 | 54.03 |
| Support Level | $23.52 | $29.26 |
| Resistance Level | $31.83 | $42.79 |
| Average True Range (ATR) | 0.95 | 2.23 |
| MACD | -0.45 | 0.75 |
| Stochastic Oscillator | 1.56 | 48.78 |
Price Performance
Historical ComparisonAbout BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.